Imupret oral drops bottle 100 ml

Instructions Imupret oral drops bottle 100 ml

Composition

active ingredients: 100 g of drops contain 29 g of water-alcoholic extract (extractant ethanol 59% (v/v)) from medicinal plants:

marshmallow root (Radix Althaeae) 0.4 g;

chamomile flowers (Flores Chamomillae) 0.3 g;

horsetail herb (Herba Equiseti) 0.5 g;

walnut leaves (Folia Juglandis) 0.4 g;

yarrow herb (Herba Millefolii) 0.4 g;

oak bark (Cortex Quercus) 0.2 g;

dandelion herb (Herba Taraxaci) 0.4 g;

excipients: ethanol 19% (v/v), purified water.

Dosage form

Oral drops.

Main physicochemical properties: transparent or slightly cloudy yellow-brown liquid with a chamomile odor. During storage, turbidity and precipitation are possible.

Pharmacotherapeutic group

Combined preparations used for coughs and colds. ATC code R05X.

Pharmacological properties

The components that make up the herbal medicine have complex activity.

Imupret®, thanks to the polysaccharides of chamomile and marshmallow, stimulates the nonspecific response of the immune system by increasing the phagocytosis of macrophages and granulocytes. These active components also increase the intracellular destruction of bacteria during phagocytosis due to the increased release of active oxygen metabolites, which have bactericidal properties. Polysaccharides, essential oils and flavonoids (chamomile, marshmallow and yarrow) reduce the swelling of the mucous membrane in respiratory tract infections. In vitro studies have shown that oak bark, which contains a lot of tannins, also has an antiviral effect on the influenza virus.

Horsetail, which is part of the preparation, enhances these effects due to its well-known healing and preventive properties.

Indication

For the treatment of diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis). Prevention of complications and relapses in respiratory viral infections due to a decrease in the body's defenses

Contraindication

Increased individual sensitivity to any of the active or auxiliary substances of the drug and to plants of the Asteraceae family.

Special safety precautions

This medicinal product contains 19% (v/v) ethanol.

Due to the ethanol content, Imupret® drops should not be prescribed after successful anti-alcohol treatment. Patients with liver diseases, epilepsy, and traumatic brain injuries can take this drug only after consulting a doctor.

During storage, the drug may become cloudy or precipitate, but this does not affect the effect of the drug.

If symptoms of the disease do not disappear after 1 week of treatment or if shortness of breath, fever, purulent or bloody sputum occurs, you should consult a doctor.

Note for diabetics: A single dose of the drug contains a small number of bread units (BSU).

Use during pregnancy or breastfeeding

Not recommended for use during pregnancy.

The ability to influence the reaction speed when driving or working with other mechanisms

There is no information about the direct effect of the drug on the ability to drive or operate other mechanisms, but it should be borne in mind that the drug contains ethanol.

Method of administration and doses

Unless otherwise prescribed, the drug is used in the following doses:

The solution should be shaken before use. The bottle should be held vertically when instilling the drug. The drops are usually taken undiluted. The specified number of drops should be held in the mouth for a short time and then swallowed. If necessary, the drops can be used with a small amount of water. Children can be given the drops by adding them to juice or tea.

Even after the acute symptoms disappear, it is advisable to continue treatment for another 1 week to prevent recurrence of the disease.

The drug is well tolerated, so it can be recommended for long-term use. For basic therapy of chronic respiratory diseases (especially tonsillitis), the drug should be used for at least 6 weeks.

Children

Should not be used in children under 1 year of age.

Overdose

Cases of drug poisoning due to overdose are unknown.

Treatment: symptomatic therapy.

Side effects

When used in combination with preparations containing chamomile flowers, allergic reactions may occur, as well as in patients with hypersensitivity to other plants of the Asteraceae family (for example, yarrow (Achillea Millefolium)).

If any adverse reactions occur, you should stop using the drug and be sure to consult a doctor.

Interaction with other medicinal products and other types of interactions

No interactions with other drugs were observed.

Preparations containing oak bark may weaken or block the absorption of alkaloids and other alkaline drugs when used simultaneously.

Expiration date

2 years.

Do not use after the expiry date stated on the packaging.

The expiration date determines the use of the drug until the last day of the month.

An opened bottle is suitable for use within 6 months.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 oC, out of the reach of children.

Packaging

100 ml in a bottle in a cardboard box.

Vacation category

Without a prescription.

Producer

Bionorica CE, Kerchensteinerstrasse 11-15, 92318 Neumarkt, Germany.

Bionorica SE, Kerschensteinerstrasse, 11-15, 92318 Neumarkt, Germany.